BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25044584)

  • 1. Diabetes mellitus: influences on cancer risk.
    Szablewski L
    Diabetes Metab Res Rev; 2014 Oct; 30(7):543-53. PubMed ID: 25044584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
    Gallagher EJ; LeRoith D
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus type 2 - an independent risk factor for cancer?
    Grote VA; Becker S; Kaaks R
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, insulin, and risk of cancer.
    Schiel R; Beltschikow W; Steiner T; Stein G
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
    McFarland MS; Cripps R
    Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort.
    Romon I; Rey G; Mandereau-Bruno L; Weill A; Jougla E; Eschwège E; Simon D; Druet C; Fagot-Campagna A
    Diabet Med; 2014 Aug; 31(8):946-53. PubMed ID: 24627972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R; Müller UA; Braun A; Stein G; Kath R
    Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and cancer: Could vitamin D provide the link?
    Ahmad S; Chowdhury TA; Boucher BJ
    J Diabetes Complications; 2013; 27(2):184-90. PubMed ID: 23164631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and cancer: placing the association in perspective.
    Andersen DK
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):81-6. PubMed ID: 23422245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist.
    Salvatore T; Marfella R; Rizzo MR; Sasso FC
    Int J Surg; 2015 Sep; 21 Suppl 1():S72-7. PubMed ID: 26123386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer more common in diabetes. Maybe the treatment itself also plays a role].
    Nilsson PM; Eliasson B
    Lakartidningen; 2010 Jan 27-Feb 2; 107(4):170-1. PubMed ID: 20333969
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
    Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
    J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of diabetes in terminal illness related to cancer.
    King EJ; Haboubi H; Evans D; Baker I; Bain SC; Stephens JW
    QJM; 2012 Jan; 105(1):3-9. PubMed ID: 21920998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
    Suh S; Kim KW
    Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.